BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12937853)

  • 1. Immunohistochemical evaluation of P21ras and P53 proteins expression in human non-small-cell lung cancers.
    Przybojewska B; Rydzynski K; Stepnik M; Jakubiak M; Kozak J; Szymczak W
    Neoplasma; 2003; 50(3):198-203. PubMed ID: 12937853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis.
    Dosaka-Akita H; Hu SX; Fujino M; Harada M; Kinoshita I; Xu HJ; Kuzumaki N; Kawakami Y; Benedict WF
    Cancer; 1997 Apr; 79(7):1329-37. PubMed ID: 9083154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
    Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T
    Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of p27KIP1 expression in resected non-small cell lung cancers: analysis in combination with expressions of p16INK4A, pRB, and p53.
    Hirabayashi H; Ohta M; Tanaka H; Sakaguchi M; Fujii Y; Miyoshi S; Matsuda H
    J Surg Oncol; 2002 Dec; 81(4):177-84; discussion 184. PubMed ID: 12451621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of p53 and ras p21 protein expression in surgically treated non-small cell lung carcinoma.
    Cohen R; Guber A; Koren R; Marom Z; Siegal A
    Rom J Morphol Embryol; 1998; 44(1-4):117-23. PubMed ID: 15678852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptotic regulators: P53 and survivin expression in non-small cell lung cancer.
    Porebska I; Sobańska E; Kosacka M; Jankowska R
    Cancer Genomics Proteomics; 2010; 7(6):331-5. PubMed ID: 21156966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 and P-glycoprotein expression do not correlate with survival in nonsmall cell lung cancer: a long-term study and literature review.
    Haque AK; Adegboyega P; Al-Salameh A; Vrazel DP; Zwischenberger J
    Mod Pathol; 1999 Dec; 12(12):1158-66. PubMed ID: 10619270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of Ang-2 mRNA in non-small cell lung cancer: association with angiogenesis and poor prognosis.
    Takanami I
    Oncol Rep; 2004 Oct; 12(4):849-53. PubMed ID: 15375511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ras p21 immunostaining in early stage squamous cervical carcinoma: relationship with lymph nodal involvement and 72 kDa-metalloproteinase index.
    Garzetti GG; Ciavattini A; Lucarini G; Goteri G; Nictolis MD; Romanini C; Biagini G
    Anticancer Res; 1998; 18(1B):609-13. PubMed ID: 9568185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of MDA-7/IL-24 and its clinical significance in resected non-small cell lung cancer.
    Ishikawa S; Nakagawa T; Miyahara R; Kawano Y; Takenaka K; Yanagihara K; Otake Y; Katakura H; Wada H; Tanaka F
    Clin Cancer Res; 2005 Feb; 11(3):1198-202. PubMed ID: 15709189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of heat shock proteins HSP70 and HSP27 in primary non-small cell lung carcinomas. An immunohistochemical study.
    Małusecka E; Zborek A; Krzyzowska-Gruca S; Krawczyk Z
    Anticancer Res; 2001; 21(2A):1015-21. PubMed ID: 11396134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of FOXP3 expression with non-small cell lung cancer.
    Dimitrakopoulos FI; Papadaki H; Antonacopoulou AG; Kottorou A; Gotsis AD; Scopa C; Kalofonos HP; Mouzaki A
    Anticancer Res; 2011 May; 31(5):1677-83. PubMed ID: 21617226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
    Gouyer V; Conti M; Devos P; Zerimech F; Copin MC; Créme E; Wurtz A; Porte H; Huet G
    Cancer; 2005 Apr; 103(8):1676-84. PubMed ID: 15754326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
    Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M
    Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced ING1b gene expression plays an important role in carcinogenesis of non-small cell lung cancer patients.
    Kameyama K; Huang CL; Liu D; Masuya D; Nakashima T; Sumitomo S; Takami Y; Kinoshita M; Yokomise H
    Clin Cancer Res; 2003 Oct; 9(13):4926-34. PubMed ID: 14581367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear p53 overexpression is an independent prognostic parameter in node-negative non-small cell lung carcinoma.
    Dalquen P; Sauter G; Torhorst J; Schultheiss E; Jordan P; Lehmann S; Solèr M; Stulz P; Mihatsch MJ; Gudat F
    J Pathol; 1996 Jan; 178(1):53-8. PubMed ID: 8778317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined analysis of cyclooxygenase-2 expression with p53 and Ki-67 in nonsmall cell lung cancer.
    Tsubochi H; Sato N; Hiyama M; Kaimori M; Endo S; Sohara Y; Imai T
    Ann Thorac Surg; 2006 Oct; 82(4):1198-204. PubMed ID: 16996907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation analysis among expression of ERCC-1, metallothionein, p53 and platinum resistance and prognosis in advanced non-small cell lung cancer].
    Huang PY; Liang XM; Lin SX; Luo RZ; Hou JH; Zhang L
    Ai Zheng; 2004 Jul; 23(7):845-50. PubMed ID: 15248926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex-specific survival advantage with parathyroid hormone-related protein in non-small cell lung carcinoma patients.
    Hastings RH; Laux AM; Casillas A; Xu R; Lukas Z; Ernstrom K; Deftos LJ
    Clin Cancer Res; 2006 Jan; 12(2):499-506. PubMed ID: 16428492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection by denaturant gradient gel electrophoresis of tumor-specific mutations in biopsies and relative bronchoalveolar lavage fluid from resectable non-small cell lung cancer.
    Ferretti G; Curigliano G; Pastorino U; Cittadini A; Flamini G; Calabrò MG; De Pas T; Orlando L; Mandalà M; Colleoni M; Spaggiari L; Granone PL; Pagliari G; de Braud F; Fazio N; Goldhirsch A
    Clin Cancer Res; 2000 Jun; 6(6):2393-400. PubMed ID: 10873091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.